发明名称 OLIGOMER-CONTAINING PYRROLIDINE COMPOUNDS
摘要 The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
申请公布号 US2014288315(A1) 申请公布日期 2014.09.25
申请号 US201414297149 申请日期 2014.06.05
申请人 NEKTAR THERAPEUTICS 发明人 Riggs-Sauthier Jennifer
分类号 C07D207/27 主分类号 C07D207/27
代理机构 代理人
主权项 1. A compound comprising a pyrrolidone residue covalently attached to two water-soluble, non-peptidic oligomers, the compound having the following structure.wherein; each L is independently selected from the group consisting of hydrogen, hydroxyl, a C1-6 alkyl radical, a C2-6 alkenyl radical, and a C2-6 alkynyl radical; p is a whole number from 1 to 6; Y is selected from the group consisting of hydrogen, a C1-6 alkyl radical, a C2-6 alkenyl radical, and a C2-6 alkynyl radical; X1 is a first spacer moiety; X2 is a second spacer moiety; POLY1 is a first water-soluble, non-peptidic oligomer having a molecular weight of below about 1500 Daltons; and POLY2 is a second water-soluble, non-peptidic oligomer having a molecular weight of below about 1500 Daltons, and pharmaceutically acceptable salts thereof.
地址 San Francisco CA US